Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs Psilocybin

Psilocybin boosts mind perception but doesn’t reduce atheism

by Mane Kara-Yakoubian
September 25, 2024
in Psilocybin
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Share on TwitterShare on Facebook

A recent study published in Journal of Psychoactive Drugs found that while psychedelic experiences increased mind perception across various entities, they did not significantly change individuals’ Atheist-Believer status.

The relationship between psychedelics and belief systems has long fascinated researchers, particularly the possibility that psychedelics like psilocybin might alter spiritual or religious beliefs. Previous cross-sectional studies suggested that psychedelic experiences could lead to shifts in metaphysical beliefs or religious identifications, with some participants reporting increased spirituality and reduced atheism after using these substances. However, these earlier studies had various biases, such as relying on retrospective accounts and self-selection among participants already interested in belief changes.

Sandeep M. Nayak and colleagues addressed these limitations by conducting a prospective longitudinal study to assess how psilocybin, a well-known psychedelic, impacts belief systems and mind perception.

The researchers conducted a prospective longitudinal study, recruiting 657 participants who had planned to undergo a psilocybin experience outside of controlled laboratory settings. The recruitment materials did not mention belief changes to avoid priming participants about potential outcomes related to their spiritual or religious views.

Participants were asked to complete surveys at multiple time points: during informed consent (baseline), two weeks before their scheduled psilocybin experience, 2-4 weeks after the experience, and again 2-3 months later. These surveys collected a wide range of data, including demographic information and specifics related to their psilocybin use, such as dosage, setting, and ingestion method, and assessments of mind perception (e.g., attribution of consciousness to various living and non-living entities), metaphysical beliefs (e.g., materialism, dualism), and Atheist-Believer status (non-believer, agnostic, or believer).

The mind perception scale measured participants’ views on the conscious experience of various entities, ranging from non-human animals and plants to inanimate objects like rocks. The metaphysical beliefs scale included items that assessed participants’ views on the nature of reality, such as whether they believed in dualism (the separation of mind and body) or materialism (the belief that all phenomena have a material explanation). The Atheist-Believer scale captured participants’ religious affiliations or spiritual beliefs before and after the psilocybin experience.

The results revealed an increase in participants’ attribution of consciousness to various living and non-living entities following their psilocybin experience, particularly non-human primates, quadrupeds (e.g., dogs and cats), insects, fungi, and plants. These shifts in mind perception were evident both at the 2-4 week follow-up and again at 2-3 months.

Participants who were psychedelic-naive—those experiencing psilocybin for the first time—showed greater increases in mind perception than those with prior psychedelic experience. In contrast, there was little to no change in participants’ metaphysical beliefs; the belief that mind and body are distinct (dualism) or that material phenomena stem from the mind (idealism) remained stable. A small increase in determinism (the belief that events are pre-determined) was observed at the 2-3 month follow-up.

Participants’ Atheist-Believer status also remained unchanged, with no significant shifts in the proportions of non-believers, agnostics, or believers, contradicting earlier studies that suggested psilocybin might increase spirituality or reduce atheism. Overall, the findings suggest that psilocybin’s effect on mind perception is stronger than its influence on core spiritual or philosophical beliefs.

Of note is that this study lacked a non-psychedelic control group, making it harder to distinguish whether the observed changes were specifically due to psilocybin.

The research, “Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study”, was authored by Sandeep M. Nayak, Sydney H. White, Samantha N. Hilbert, Matthew X. Lowe, Heather Jackson, Roland R. Griffiths, Albert Garcia-Romeu, and David B. Yaden.

RELATED

Major new study finds psilocybin microdoses improve the quality of creative ideas but not the quantity
Microdosing

Major new study finds psilocybin microdoses improve the quality of creative ideas but not the quantity

January 24, 2026
How credible is psilocybin-assisted therapy? Study suggests people are cautious about psychedelic treatment for depression
Psilocybin

Psilocybin shows promise for rapid reduction of cancer-related depression

December 28, 2025
Single moderate dose of psilocybin linked to temporary reduction in OCD symptoms
Psilocybin

Single moderate dose of psilocybin linked to temporary reduction in OCD symptoms

December 21, 2025
Childhood adversity linked to poorer cognitive function across different patterns of aging
Anxiety

Psilocybin helps the brain unlearn fear by silencing specific neural pathways

December 8, 2025
Analysis of 45 serial killers sheds new light on the dark psychology of sexually motivated murderers
Mental Health

The booming market for mushroom edibles has a hidden and potentially toxic problem

November 27, 2025
Analysis of 45 serial killers sheds new light on the dark psychology of sexually motivated murderers
Neuroimaging

Scientists pinpoint cellular mechanism behind psilocin’s effects on brain activity

November 19, 2025
Psychedelic mushrooms and quiet quitting: Psilocybin use tied to working fewer overtime hours
Depression

Psilocybin therapy linked to lasting depression remission five years later

October 27, 2025
New study highlights psilocybin’s promise for major depressive disorder treatment
Psilocybin

Psilocybin therapy linked to reduced suicidal thoughts in people with psychiatric disorders

October 9, 2025

PsyPost Merch

STAY CONNECTED

LATEST

New research maps the psychological pathway from body appreciation to relationship satisfaction

Motivation acts as a camera lens that shapes how memories form

Popular lyrics keep getting darker and dumber, but there was a surprising shift during the first Trump presidency

Genetic factors likely confound the link between c-sections and offspring mental health

Major new study finds psilocybin microdoses improve the quality of creative ideas but not the quantity

Donald Trump weaponizes humor through “dark play” to test boundaries

Severe sleep problems is associated with fewer years of healthy brain function

Childhood adversity linked to accelerated biological aging in women, new study finds

RSS Psychology of Selling

  • New research links faking emotions to higher turnover in B2B sales
  • How defending your opinion changes your confidence
  • The science behind why accessibility drives revenue in the fashion sector
  • How AI and political ideology intersect in the market for sensitive products
  • Researchers track how online shopping is related to stress
         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy